RSS
14 Apr 2023

Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial Presented at NKF Spring Clinical Meetings

Author: admintech | Filed under: Press Release

AUSTIN, Texas, April 14, 2023 /PRNewswire/ — The main results of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) trial, a National Heart, Lung, and Blood Institute (NHLBI) sponsored trial were presented. Although the…

This entry was posted on Friday, April 14th, 2023 at 7:12 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»